Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2002-9-18
pubmed:abstractText
Addition of ubiquitin or ubiquitin chains to target proteins leads to their mono- or polyubiquitination, respectively. Whereas polyubiquitination targets proteins for degradation, monoubiquitination is thought to regulate receptor internalization and endosomal sorting. Cbl proteins are major ubiquitin ligases that promote ligand-dependent polyubiquitination and degradation of receptor tyrosine kinases. They also recruit CIN85-endophilin in the complex with activated receptors, thus controlling receptor endocytosis. Here we show that the adaptor protein CIN85 and its homologue CMS are monoubiquitinated by Cbl/Cbl-b after epidermal growth factor (EGF) stimulation. Monoubiquitination of CIN85 required direct interactions between CIN85 and Cbl, the intact RING finger domain of Cbl and a ubiquitin acceptor site present in the carboxyl terminus of CIN85. Cbl-b and monoubiquitinated CIN85 are found in the complex with polyubiquitinated EGF receptors during prolonged EGF stimulation and are degraded together in the lysosome. Dominant interfering forms of CIN85, which have been shown previously to delay EGF receptor degradation, were also impaired in their monoubiquitination. Thus, our data demonstrate that Cbl/Cbl-b can mediate polyubiquitination of cargo as well as monoubiquitination of CIN85 to control endosomal sorting and degradation of receptor tyrosine kinases.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-10449328, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-10481267, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-10514377, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-10635327, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-10679202, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-10921882, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11067845, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11071869, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11152963, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11208108, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11223029, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11251082, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11283727, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11375397, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11493652, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11511343, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11551499, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11864992, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11894095, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11894096, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-11919637, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-2158859, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-2344614, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-2374607, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-8395172, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-8662849, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-8939994, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-9039260, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-9174060, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-9234717, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-9666441, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-9704404, http://linkedlifedata.com/resource/pubmed/commentcorrection/12218189-9851973
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adaptor Proteins, Signal Transducing, http://linkedlifedata.com/resource/pubmed/chemical/CD2-associated protein, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Cytoskeletal Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Protein v-cbl, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Retroviridae Proteins, Oncogenic, http://linkedlifedata.com/resource/pubmed/chemical/SH3KBP1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
17
pubmed:volume
99
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
12191-6
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors.
pubmed:affiliation
Ludwig Institute for Cancer Research, Box 595, Husargatan 3, S-75124 Uppsala, Sweden.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't